Historical overview and current practice of peritoneal dialysis in Japan

Abstract In the early days of peritoneal dialysis (PD) therapy, its limited duration and deterioration were argued to be disadvantages. Biocompatible solutions hybrid therapy have been used in Japan overcome these issues, which resulted a decrease encapsulating sclerosis (EPS) incidence an extension PD continuation; results disseminated worldwide. Peritoneal outcomes practice patterns study (PDOPPS), prospective observational study, has begun confirm sufficient evidence published, influenced preparation guidelines. Current thinking about emphasizes need maintain quality life goals as care for patients provide high-quality care. However, we must conduct basic research on prevention deterioration.